UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934

AMRYT PHARMA PLC

(Exact Name of Registrant as Specified in its Charter)

England and Wales	Not Applicable
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

Dept 920a 196 High Road, Wood Green,

London, United Kingdom, N22 8HH

Tel: +44 (0)20 3026 7257

(Address of principal executive offices and zip code)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class to be so registered	Name of each exchange on which each class is to be registered
American Depositary Shares, each representing five ordinary shares	The Nasdaq Stock Market LLC
Ordinary shares, nominal value £0.06 per share	The Nasdaq Stock Market LLC*

* Not for trading, but only in connection with the registration of the American Depositary Shares on The Nasdaq Stock Market LLC. The American Depositary Shares represent the right to receive the ordinary shares and are being registered under the Securities Act of 1933, as amended, pursuant to a separate Registration Statement on Form F-6. Accordingly, the American Depositary Shares are exempt from the operation of Section 12(a) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 12a-8 thereunder.

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-239395

Securities to be registered pursuant to Section 12(g) of the Act: None.

INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 1.Description of Registrant’s Securities to be Registered.

Amryt Pharma plc (the “Registrant”) hereby incorporates by reference (a) the description of its ordinary shares, nominal value £0.06 per share, to be registered hereunder, contained under the heading “Description of Share Capital and Certain Corporate Matters” (b) the description of its American Depositary Shares, each representing five ordinary shares, to be registered hereunder, contained under the heading “Description of American Depositary Shares” and (c) the information set forth under the heading “Income Tax Considerations,” in each case, in the Registrant’s Registration Statement on Form F-1 (File No. 333-239395), as originally filed with the Securities and Exchange Commission (the “Commission”) on June 23, 2020, as subsequently amended (the “Registration Statement”), and any prospectus that constitutes part of the Registration Statement and that is subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which information shall be deemed to be incorporated herein by reference.

Item 2.Exhibits.

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

	Amryt Pharma plc
	By:	/s/ Rory Nealon
	Name:	Rory Nealon
	Title:	Chief Financial Officer and Chief Operating Officer
Date: July 1, 2020